Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in RA Patients with Inadequate Response to Methotrexate
NCT01000610Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2008
- Primary completion
- May 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Primary endpoint: Number of Participants Reporting Adverse Events at 104 weeks. Started Mar 2008; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01000610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01000610.